Last reviewed · How we verify

NCT01191593

The Efficacy of Adductor-Canal-Blockade on Pain and Morphine Consumption After Revision Knee Arthroplasty

Completed Phase 4 Last updated 21 August 2013
What this trial tests

Phase 4 trial testing Adductor-Canal-Blockade with Ropivacaine in Postoperative Pain in 36 participants. Completed in 1 April 2013.

Timeline
1 September 2010
Primary endpoint
1 April 2013
1 April 2013

Quick facts

Lead sponsorRigshospitalet, Denmark
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment36
Start date1 September 2010
Primary completion1 April 2013
Estimated completion1 April 2013
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Rigshospitalet, Denmark

Who can join

Adults 40 to 85, any sex, with Postoperative Pain or Knee Arthroplasty. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The purpose of this study is to determine whether Adductor-Canal-Blockade is effective at reducing pain and morphine consumption after revision knee arthroplasty.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Adductor canal block for postoperative pain treatment after revision knee arthroplasty: a blinded, randomized, placebo-controlled study.
    Jæger P, Koscielniak-Nielsen ZJ, Schrøder HM, Mathiesen O, et al · · 2014 · cited 33× · PMID 25386752 · DOI 10.1371/journal.pone.0111951

Verify or expand the search:

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01191593.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing